The Consortium for Canine Comparative Oncology (C3O) is a collaboration between the Duke Cancer Institute and North Carolina State University College of Veterinary Medicine. Duke and NC State have joined forces to further explore new cancer therapies offering better efficacy and less toxicity for both humans and canines. Researchers at both institutions are studying naturally occurring cancers in humans and canines and this collaboration will allow investigators to leverage research and resources to benefit both species, ensuring better treatments and outcomes.
D. Paul Lunn, BVSc, MS, PhD, MRCVS, Dip. ACVIM, is the Dean of the College of Veterinary Medicine at North Carolina State University.
Michael Kastan, MD, PhD, is the Executive Director of the Duke Cancer Institute.